Themed collection Sustainable Medicinal Chemistry
The many facets of sustainability in medicinal chemistry: our personal experience
Sustainability cannot be an afterthought; it must be embedded into every framework of medicinal chemistry.
RSC Med. Chem., 2026,17, 738-742
https://doi.org/10.1039/D5MD00882D
From lab to environment: forecasting pharmaceutical impact using in silico and analytical tools
This review highlights in silico tools (QSAR, machine learning, molecular docking) and advanced analytical methods, including ion mobility spectrometry, for predicting and validating pharmaceutical persistence, toxicity, and bioaccumulation.
RSC Med. Chem., 2026,17, 768-783
https://doi.org/10.1039/D5MD01000D
Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products
Biocatalysis has ascended as a defining force in contemporary total synthesis, furnishing catalytic modalities that deliver molecular complexity with unparalleled chemo-, regio-, and stereo-control.
RSC Med. Chem., 2026, Advance Article
https://doi.org/10.1039/D5MD01011J
Integrating green synthesis and liquid–liquid extraction of lidocaine in deep eutectic solvents
A DES-to-DES process enables one-pot lidocaine synthesis with solvent-free isolation, while eutectic media serve as reaction solvents, extraction agents and formulation platforms, enabling reduced PMI and greener pharmaceutical processing.
RSC Med. Chem., 2026, Advance Article
https://doi.org/10.1039/D5MD00922G
Oxyprenyl–chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction
The escalating threat of antimicrobial resistance (AMR) compels the development of novel antibiotics with broad spectrum activity and environmentally responsible degradation profiles.
RSC Med. Chem., 2026, Advance Article
https://doi.org/10.1039/D5MD00839E
Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action
Tanshinone I, IIA, and cryptotanshinone from Salvia miltiorrhiza inhibit M. tuberculosis, including resistant strains, showing low toxicity, high selectivity, and potential cell wall targeting suggested by morphological and genomic analyses.
RSC Med. Chem., 2025,16, 6020-6030
https://doi.org/10.1039/D5MD00637F
Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach
Microwave-assisted synthesis of new pyrrole and indole derivatives as tubulin assembly inhibitors was performed with remarkably improved yields and short reaction times.
RSC Med. Chem., 2025,16, 4845-4858
https://doi.org/10.1039/D5MD00406C